XPH

SPDR$62.70-0.96 (-1.51%)
AUM $510.3MER 0.35%NAV $63.79Holdings 62

Price Chart

Key Statistics

Previous Close

$63.66

Day Range

$62.17$63.95

52-Week Range

$47.32$74.06

Avg Volume

236.7K

Dividend Yield

0.84%

Expense Ratio

0.35%

AUM

$510.3M

Shares Outstanding

4.0M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States96.00%
Ireland3.94%
Other0.06%

Fund Information

Issuer
SPDR
Category
Healthcare
Inception Date
Jun 19, 2006
Exchange
NYSE_ARCA
Description
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Similar ETFs

SymbolNameAUM
SCHDSchwab U.S. Dividend Equity ETF$108.39B
IWMiShares Russell 2000 ETF$77.54B
XLVState Street Health Care Select Sector SPDR ETF$42.73B
VHTVanguard Health Care ETF$22.00B
SCHASchwab U.S. Small-Cap ETF$21.79B

The State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund issued by SPDR that launched on Jun 19, 2006. It currently manages $510.3M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 62 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 21.8% of the fund

RankSymbolNameWeight %SharesMarket Value
1XERSXERIS BIOPHARMA HOLDINGS INC2.43%1,283,581$12.7M
2MANEVERADERMICS INC2.39%99,295$12.5M
3AMRXAMNEAL PHARMACEUTICALS INC2.36%573,709$12.4M
4VTRSVIATRIS INC2.15%599,780$11.2M
5LGNDLIGAND PHARMACEUTICALS2.13%34,352$11.2M
6ANIPANI PHARMACEUTICALS INC2.09%139,981$11.0M
7LLYELI LILLY + CO2.07%8,798$10.9M
8INDVINDIVIOR PHARMACEUTICALS INC2.06%284,626$10.8M
9PFEPFIZER INC2.05%356,247$10.8M
10OGNORGANON + CO2.03%723,948$10.7M
11SUPNSUPERNUS PHARMACEUTICALS INC2.03%235,239$10.7M
12DFTXDEFINIUM THERAPEUTICS INC2.01%260,504$10.5M
13CORTCORCEPT THERAPEUTICS INC2.00%85,539$10.5M
14PRGOPERRIGO CO PLC1.98%690,121$10.4M
15MRKMERCK + CO. INC.1.98%67,076$10.4M
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
-1.51%
1W
-4.81%
1M
-10.61%
3M
-10.19%
6M
+12.68%
YTD
+13.95%
1Y
+30.14%
3Y
+60.98%
5Y
+33.74%

Moving Averages

20-Day MA

$66.40

Below 20-Day MA
50-Day MA

$69.04

Below 50-Day MA
200-Day MA

$61.09

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$74.06

Current Price

$62.70

52-Week Low

$47.32

$47.32$74.06

Current Yield

0.84%

Annual Dividend

$0.2747

Frequency

4x/year

Last Ex-Date

Sep 21, 2026

Dividend History

Ex-DateAmountPay Date
Sep 21, 2026$0.0416Sep 23, 2026
Jun 22, 2026$0.0590Jun 24, 2026
Mar 23, 2026$0.0610Mar 25, 2026
Dec 22, 2025$0.1130Dec 24, 2025
Dec 22, 2025$0.1130Dec 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Jun 23, 2025$0.0959Jun 25, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Dec 23, 2024$0.1548Dec 26, 2024
Dec 23, 2024$0.1548Dec 26, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Dec 18, 2023$0.1744Dec 21, 2023
Dec 18, 2023$0.1744Dec 21, 2023

Dividend Payments Over Time

Category Comparison

MetricXPHHealthcare(231 ETFs)Equal Weight(109 ETFs)
Fund Info
Expense Ratio0.35%0.62%0.68%
AUM$510.3M$1.98B$1.71B
Dividend Yield0.84%4.11%2.87%
Avg Volume236.7K491.6K559.4K
Holdings62178192
Performance
1-Month Return-11.31%-4.15%-2.14%
6-Month Return+6.84%+5.09%+3.56%
YTD Return+12.32%+9.06%+13.72%
1-Year Return+13.95%+8.39%+10.20%

Compare with Another ETF

Search for an ETF to compare with XPH:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.